Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Board/Management Information 2018

Mar 20, 2018

65285_rns_2018-03-20_199b92db-ae84-4f17-ad2a-624cefb93a88.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

ASX Announcement 2018

26 February

ASX Announcement

21 March 2018

Mach7 Establishes Industry Advisory Board

Mr Per Larsen Appointed to Mach7 Industry Advisory Board

Melbourne, Australia; 21 March 2018: Mach7 Technologies Limited ( Mach7 or the Company ) (ASX:M7T) announced today it has established an industry advisory board, and has appointed its first member, Mr Per Larsen.

The purpose of the advisory board is to advise the Board and executive management on key healthcare/information technology matters including business strategy, product development initiatives, competitive landscape, new markets and providing introductions to valuable partners and potential customers.

Mach7 welcomes Mr Per Larsen to its advisory board as its first member. Mr Larsen is an accomplished international business executive with an impressive 30+ year track record. He is currently working as an advisor to businesses in USA and in Europe including as a member of the City of Richardson, Texas International Business Advisory Council. He is also a member of the Dallas - Fort Worth Metroplex Technology Business Council. His most recent engagements also include serving as a Senior Vice President at a late stage U.S. technology startup as well as being on the boards of 3 technology companies based in Denmark. Previously, he has held senior executive roles with IBM in Europe and in USA as well as Olicom, a leading I.T. and banking automation group.

Mr Larsen’s background in large international technology businesses makes him a valuable advisor for the leadership of global businesses such as Mach7. He brings a practical approach to strategy development and creating associated execution plans.

Mike Jackman, Mach7 CEO said, “Establishing the Mach7 industry advisory board, comprising veteran software and healthcare I.T. domain experts, is another important step in building a strong, high growth, sustainable business.”

“I am honoured to be selected for this advisory board” said Per Larsen, “and I am looking forward to assisting the Mach7 team continue on its exceptional global growth path.”

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative data management solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit www.mach7t.com.

==> picture [596 x 119] intentionally omitted <==

ASX Announcement 2018

26 February

21 March 2018

ASX Announcement

For more information, contact :

Mike Jackman CEO, Mach7 +1 802 391 8229 (U.S.) [email protected]

Jenni Pilcher CFO, Mach7 +61 3 9286 7500 (Australia) [email protected]

Andrew Keys

Investor Relations, Keys Thomas Associates +61 400 400380 (Australia) [email protected]

==> picture [596 x 119] intentionally omitted <==